Neuromuscular Blockade Clinical Trial
Official title:
Comparison of Electromyography-based TetraGraph and Acceleromyography-based TOF-Watch SX Neuromuscular Monitors Under Clinical Conditions
NCT number | NCT03987607 |
Other study ID # | AITT2017/3 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 17, 2019 |
Est. completion date | December 18, 2019 |
Verified date | December 2019 |
Source | University of Debrecen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Anesthesiologists are often required to give certain drugs, called muscle relaxants to the patients for surgery. These drugs make the people weak for the procedure to make the work of the surgeon easier and prevent unexpected movements. The effect of these drugs must be terminated by the end of the procedures to ensure that the patients can breathe normally. Over the years several monitors have been developed to monitor the effect of these drugs. The monitors use different principles to measure muscle function. Some monitors are integrated into anesthesia machines while others are battery-operated, portable devices. The aim of the present study is two compare monitors using different technologies. Both monitors stimulate a peripheral nerve at the wrist that makes the thumb twitch. The older device (TOF-Watch SX) measures the acceleration of thumb movement, the new device (TetraGraph) measures the electrical activity of the muscle that moves the thumb. The two devices will be connected so that with one simulation both types of signals can be recorded and analyzed. The monitors will be used during the surgeries as described by the manufacturer. The study will not influence the surgical procedure or the anesthetic of the patients. The aim of the study is to collect data on how the two monitors correlate, since they measure neuromuscular function by different technologies (acceleromyography and electromyography).
Status | Completed |
Enrollment | 50 |
Est. completion date | December 18, 2019 |
Est. primary completion date | December 18, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - elective surgery requiring neuromuscular blockade - written informed consent - American Society of Anesthesiology physical status I-III Exclusion Criteria: - neuromuscular disease in patient history, - patient taking any medication that affects neuromuscular transmission, - open wound or sores at the site of electrode placement, - expected difficult airway, - pregnancy or breastfeeding state, - implanted pacemaker |
Country | Name | City | State |
---|---|---|---|
Hungary | University of Debrecen, Department of Anesthesiology and Intensive Care | Debrecen |
Lead Sponsor | Collaborator |
---|---|
Tamas Vegh, MD | Senzime AB |
Hungary,
Kopman AF, Chin W, Cyriac J. Acceleromyography vs. electromyography: an ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation. Acta Anaesthesiol Scand. 2005 Mar;49(3):316-22. — View Citation
Liang SS, Stewart PA, Phillips S. An ipsilateral comparison of acceleromyography and electromyography during recovery from nondepolarizing neuromuscular block under general anesthesia in humans. Anesth Analg. 2013 Aug;117(2):373-9. doi: 10.1213/ANE.0b013e3182937fc4. Epub 2013 Jul 2. Erratum in: Anesth Analg. 2017 May;124(5):1745. — View Citation
Naguib M, Brull SJ, Johnson KB. Conceptual and technical insights into the basis of neuromuscular monitoring. Anaesthesia. 2017 Jan;72 Suppl 1:16-37. doi: 10.1111/anae.13738. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.8-1.0 | Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.8-1.0 | Prior to extubation | |
Secondary | o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.6-0.79 | o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.6-0.79 | During surgery | |
Secondary | o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.4-0.59 | o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.4-0.59 | During surgery | |
Secondary | o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.2-0.39 | o Agreement between acceleromyography and electromyography derived TOF ratios in the recovery range of 0.2-0.39 | During surgery | |
Secondary | o Agreement between acceleromyography and electromyography derived TOF counts | o Agreement between acceleromyography and electromyography derived TOF counts | During surgery | |
Secondary | o Agreement between acceleromyography and electromyography derived PTC counts | o Agreement between acceleromyography and electromyography derived PTC counts | During surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05558969 -
The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex
|
N/A | |
Completed |
NCT03168308 -
Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients
|
Phase 4 | |
Not yet recruiting |
NCT03978780 -
Erector Spinae Block vs. Placebo Block Study
|
N/A | |
Completed |
NCT02912039 -
Electromyographic Assessment of the TetraGraph in Normal Volunteers
|
||
Completed |
NCT02892045 -
Mindray Neuromuscular Transmission Transducer
|
||
Completed |
NCT03427385 -
Minimum Local Anesthetic Dose for Adductor Canal Block
|
N/A | |
Completed |
NCT01450813 -
The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy
|
N/A | |
Completed |
NCT00535496 -
Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698)
|
Phase 3 | |
Recruiting |
NCT05794503 -
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
|
Early Phase 1 | |
Not yet recruiting |
NCT05993390 -
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04609410 -
Bleeding in Laparoscopic Liver Surgery
|
N/A | |
Terminated |
NCT03649672 -
The Validity and Tolerability of Awake Calibration of the TOF Watch SX Monitor
|
N/A | |
Completed |
NCT05687253 -
Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery
|
Phase 2 | |
Completed |
NCT05474638 -
Comparison of Mechanomyographic 100 Versus 200 Hz 5 Second Tetanic Fade Ratios During Neuromuscular Block Recovery
|
N/A | |
Completed |
NCT05120999 -
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
|
||
Completed |
NCT03572413 -
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.
|
Phase 4 | |
Completed |
NCT03608436 -
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery
|
Phase 4 | |
Recruiting |
NCT02930629 -
Residual Block in Postoperative Anaesthetic Care Unit
|
N/A | |
Completed |
NCT02932254 -
Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex
|
Phase 4 | |
Completed |
NCT01828385 -
Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex
|
Phase 4 |